May 2020, Volume 6, Issue 6

May 2020

Volume 6, Issue 6

This issue examines the potential for artificial intelligence to enhance clinical practice, the costs of pursuing cancer cures, and more.

Table of Contents

May 2020 Issue

Help Me Help You

Friday, May 1st, 2020
Laura Zitella, RN, ACNP-BC, AOCN, and Carrie Peterson, DNP, RN, AGNP-c, share advice for creating a successful, long-lasting mentor-mentee relationship.How do you work together?...

Editor’s Corner: At World’s End

Friday, May 1st, 2020
Just before the first deaths from the SARS-CoV-2 virus were reported in the U.S. and the Commonwealth of Massachusetts declared a state of emergency,...

The Costs of Pursuing Cancer Cures

Friday, May 1st, 2020
In this edition, Jori May, MD, reviews The First Cell: And the Human Costs of Pursuing Cancer to the Last, in which hematologist-oncologist Azra...

May 2020 Issue

Isatuximab-irfc Approved for Multiple Myeloma

Friday, May 1st, 2020
The FDA has approved the anti-CD38 monoclonal antibody isatuximab-irfc, in combination with pomalidomide and dexamethasone, for adults with multiple myeloma (MM) who have received...
Blood donation

FDA Updates Blood Donor Eligibility Guidelines

Friday, May 1st, 2020
To help address the need for blood donations amid the COVID-19 outbreak, the FDA has expanded blood donor eligibility guidelines. These guideline changes were...

Luspatercept-aamt Approved for Anemia in Adults With MDS

Friday, May 1st, 2020
The FDA has approved luspatercept-aamt for the treatment of anemia that requires 2 or more red blood cell transfusions over 8 weeks in adults...
The Society Pages

CPRIT Awards $19.6 Million to MD Anderson, Sidney Kimmel Establishes Philadelphia T-cell Lymphoma/Leukemia Initiative,...

Friday, May 1st, 2020
Sidney Kimmel Cancer Center at Jefferson Establishes Philadelphia T-cell Lymphoma/Leukemia Initiative The Sidney Kimmel Cancer Center – Jefferson Health (SKCC at Jefferson) will use a...

FDA Approves Coagulation Factor VIIa (Recombinant)-jncw for Hemophilia

Friday, May 1st, 2020
The FDA has approved coagulation factor VIIa (recombinant)-jncw to control bleeding in patients aged 12 years and older with hemophilia A or B with...
WIB_icon

Daratumumab Monotherapy Produces Rapid, Deep Hematologic Responses in Light Chain Amyloidosis

Friday, May 1st, 2020
In a study of previously treated patients with systemic light chain amyloidosis (AL), nearly half of patients treated with intravenous (IV) daratumumab experienced at...

Ropeginterferon Alfa-2b Leads to More Durable Responses Than Hydroxyurea in PV

Friday, May 1st, 2020
Patients with polycythemia vera were more likely to achieve durable long-term hematologic response with ropeginterferon alfa-2b than the standard cytoreductive therapy hydroxyurea, according to...
WIB_icon

Temozolomide Demonstrates High Response in Older Patients With Primary Vitreoretinal Lymphoma

Friday, May 1st, 2020
Temozolomide demonstrated a high overall response rate in a study of patients with primary vitreoretinal lymphoma (PVRL) who were either considered ineligible for intensive...
WIB_icon

Twice-Daily Low-Dose Aspirin Improves Antiplatelet Response in Essential Thrombocythemia

Friday, May 1st, 2020
Once-daily aspirin 75 to 100 mg is the current recommended antithrombotic regimen for patients with essential thrombocythemia (ET), but once-daily aspirin may not be...

High Bleeding Events in SCD Warrant Consideration of In-Hospital Ulcer Prophylaxis

Friday, May 1st, 2020
By the time they reach age 40, 21% of patients with sickle cell disease (SCD) will have experienced a bleeding event, with most events...

Men Have More Published Research Than Women, Regardless of Caregiving Responsibilities

Friday, May 1st, 2020
Previous research has shown that hematologists who participated in the American Society of Hematology’s (ASH’s) Clinical Research Training Institute (CRTI) experienced greater levels of...
ASH Directions

ASH Research Collaborative Data Hub Launches COVID-19 Registry for Hematology

Friday, May 1st, 2020
The ASH Research Collaborative’s (ASH RC’s) Data Hub recently launched a new COVID-19 Registry for Hematology, a global registry with clinical data on people...

Comparing Risks of Hypophosphatemia With Intravenous Formulations in Iron-Deficiency Anemia

Friday, May 1st, 2020
For patients with iron-deficiency anemia who are intolerant of or unresponsive to oral iron, intravenous formulations can rapidly correct iron deficiency, but certain formulations...

May 2020 Issue

Pulling Back the Curtain: Abraham Verghese, MD

Friday, May 1st, 2020
In this edition, Abraham Verghese, MD, describes his childhood in Ethiopia, lessons learned from patients during the HIV/AIDS epidemic, and the roots of his...

Clonal Hematopoiesis in Allogeneic Transplantation: Should It Influence Donor Selection?

Friday, May 1st, 2020
Clonal hematopoiesis (CH), the presence of hematopoietic stem/precursor cells with somatic mutations, is a defining feature of hematologic malignancies. However, CH also occurs widely...

Medicine and Machines

Friday, May 1st, 2020
As artificial intelligence applications broaden, experts advise physicians to approach them as tools – not threats. Tools have been invented to aid physicians and improve...

Volunteering to Improve Cancer Care in Cambodia

Friday, May 1st, 2020
Less than a decade ago, when children with cancer arrived at the Angkor Hospital for Children (AHC) in Siem Reap in northwest Cambodia, the only treatment available...

Demystifying PCR-Based Molecular Monitoring in CML

Friday, May 1st, 2020
When imatinib, the first tyrosine kinase inhibitor (TKI), was approved for the treatment of chronic myeloid leukemia (CML) in 2001, the disease’s natural history...

May 2020 Issue

You Make the Call

You Make the Call: Would rituximab re-treatment help this patient with hemolytic anemia?

Friday, May 1st, 2020
This month, Edward Benz Jr., MD, discusses treatment of Coombs-positive hemolytic anemia in a patient who declines to undergo splenectomy.I am caring for a...

May 2020 Issue